Clearblue® Partners with Be My Eyes to Provide Accessible Service Vision-Impaired Women Across the Globe Deserve
October 10 2019 - 8:00AM
Business Wire
Blind and low-vision women can now receive
pregnancy test results in a safe, private space with no judgment,
with support from Clearblue® Customer Careline advisors
For women with low to no vision, vision impairment can hinder
their ability to read the results of a pregnancy test on their own,
which is an intimate and private moment. Did you know nearly four
million American women have a vision impairment?1
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20191010005443/en/
Clearblue(R) Digital Pregnancy Test Image
(Photo: Business Wire)
Today on #WorldSightDay2019, Clearblue® is pleased to
announce the launch of a new accessible service, in partnership
with Be My Eyes, which helps vision-impaired women be the first to
learn their pregnancy test results in a more private setting. Be My
Eyes is a free app that connects blind and low-vision people with
sighted volunteers or company representatives for vision assistance
through a live phone connection. Women who take a Clearblue®
pregnancy test can make a video call to a Clearblue® expert
advisor through the Specialized Help function in the app. From
there, the Clearblue® advisor will read the pregnancy test
result to them or answer their questions about taking the test,
alleviating the stress of having to rely on friends and family for
help.
One of the champions of this partnership is Sumaira Latif,
P&G’s Accessibility Leader. As a vision-impaired woman herself,
Latif personally experienced the difficult task of taking a
pregnancy test without family in town to help her. After arriving
at a local pharmacy for her test results, the pharmacist declined
to help her.
“No matter the outcome, taking a pregnancy test is an emotional
and a deeply personal experience, and the result should be
something you share on your own terms,” Latif said. “We want
Clearblue® pregnancy tests to become accessible to everyone,
including the four million American women that live with a visual
disability,1 and we want to serve them.”
Clearblue® Careline Manager, Sally Haworth, noted that
members of the blind community also brought this issue to the
brand’s attention. This further inspired them to find a solution
for those blind and low-vision people who need an accessible
service for pregnancy results.
“We heard from the Clearblue® social community that they
wanted to be in control of their reproductive health information
and really wanted to be able to access their results in private,”
Haworth said. “We knew we needed a fast solution, so we’ve
partnered with Be My Eyes for a quick accessibility link to our
service, giving women the clear answers they want and deserve.”
The Clearblue® partnership with Be My Eyes is not only
revolutionary for the brand, but for vision impaired women in
English-speaking countries across the globe. Blind and low-vision
women now have an option to receive their test results in a safe,
private space with no judgment and full support from
Clearblue® Customer Careline Advisors.
To learn more about the initiative, please watch our video and
visit Clearblue.com. To download the Be My Eyes app, visit the App
Store on iOS or Android, and join the conversation by using the
hashtags #ClearblueConfirmed, #BeMyEyes and #WorldSightDay2019.
About Clearblue®
Clearblue® is the World’s No.1 selling brand in home
pregnancy and fertility tests.2 Consumers trust the
Clearblue® brand because it delivers the accurate
information they want. The Clearblue® product range is built
on a strong foundation of peer-reviewed science and consumer
understanding. Clearblue® is supported by over 30 years of
expertise, quality, and innovation in consumer diagnostics.
Clearblue® pregnancy, fertility and ovulation products are
developed with leading healthcare experts and Clearblue® is
the #1 OB-GYN Recommended ovulation brand.3 The Clearblue®
family of products include the Clearblue® Fertility Monitor,
Clearblue® Advanced Digital Ovulation Test, Clearblue®
Connected Ovulation Test System, Clearblue® Digital
Ovulation Test, Clearblue® Easy Ovulation Test,
Clearblue® Digital Pregnancy Test, and Clearblue®
Rapid Detection Pregnancy Test. For more information visit
www.clearblue.com.
ABOUT PROCTER & GAMBLE
P&G serves consumers around the world with one of the
strongest portfolios of trusted, quality, leadership brands,
including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®,
Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head &
Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®,
Tide®, Vicks®, and Whisper®. The P&G community includes
operations in approximately 70 countries worldwide. Please visit
http://www.pg.com for the latest news and information about P&G
and its brands.
1 According to the National Federation for the Blind.
2 Based on international sales compiled using independent market
research data (Data on file).
3 Research into recommendation of ovulation tests &
fertility monitors with 205 US Ob-Gyns. (Kantar health, 2017).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191010005443/en/
Velvet Gogol Bennett P&G Personal Health Care North America
& Global Communications 513-634-5576 gogolbennett.vc@pg.com
Jennifer Lawson MSL New York 917-583-6317
jennifer.lawson@mslgroup.com
Procter and Gamble (NYSE:PG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Procter and Gamble (NYSE:PG)
Historical Stock Chart
From Apr 2023 to Apr 2024